We are live on ! Find out more
DNA icon

Ginkgo Bioworks
DNA

165 hedge funds and large institutions have $375M invested in Ginkgo Bioworks in 2025 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 46 increasing their positions, 34 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more call options, than puts

Call options by funds: $22.1M | Put options by funds: $9.64M

105% more capital invested

Capital invested by funds: $183M → $375M (+$192M)

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

35% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 34

3% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 35

0.76% more ownership

Funds ownership: 71.16% → 71.93% (+0.76%)

0% more funds holding

Funds holding: 165 → 165 (0)

Holders
165
Holders Change
–
Holders Change %
0%
% of All Funds
2.17%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.07%
New
36
Increased
46
Reduced
34
Closed
35
Calls
$22.1M
Puts
$9.64M
Net Calls
+$12.5M
Net Calls Change
+$10.3M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$14M
2
National Bank of Canada
National Bank of Canada
Quebec, Canada
+$3.83M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$3.71M
4
Goldman Sachs
Goldman Sachs
New York
+$3.53M
5
PGCM
Prescott Group Capital Management
Oklahoma
+$3.18M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$8.34M
2
OM
Opaleye Management
Massachusetts
-$5.38M
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$3.24M
4
CSS
Cubist Systematic Strategies
Connecticut
-$3.2M
5
PP
PDT Partners
New York
-$2.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
CBA
26
Coastal Bridge Advisors
Connecticut
$3.11M +$2.14M +276,817 New
LIM
27
Lingotto Investment Management
United Kingdom
$2.82M – – –
Two Sigma Investments
28
Two Sigma Investments
New York
$2.29M -$857K -110,616 -35%
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$2.1M +$512K +66,100 +55%
SFI
30
Susquehanna Fundamental Investments
Pennsylvania
$2.06M – – –
AQR Capital Management
31
AQR Capital Management
Connecticut
$1.84M +$37.6K +4,851 +3%
Invesco
32
Invesco
Georgia
$1.8M +$512K +66,121 +71%
FIA
33
FNY Investment Advisers
New York
$1.69M +$127K +16,380 +12%
GCM
34
Glenview Capital Management
New York
$1.68M -$295K -38,122 -20%
MAM
35
Monaco Asset Management
Monaco
$1.41M -$407K -52,500 -30%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$1.34M +$716K +92,395 +350%
ACM
37
AH Capital Management
California
$1.22M – – –
Universal-Beteiligungs- und Servicegesellschaft
38
Universal-Beteiligungs- und Servicegesellschaft
Germany
$1.13M -$23.2K -2,995 -3%
Verition Fund Management
39
Verition Fund Management
Connecticut
$1.06M +$775 +100 +0.1%
T. Rowe Price Associates
40
T. Rowe Price Associates
Maryland
$990K +$105K +13,613 +18%
UBS AM
41
UBS AM
Illinois
$922K +$292K +37,735 +85%
Barclays
42
Barclays
United Kingdom
$856K +$222K +28,712 +61%
PP
43
PDT Partners
New York
$770K -$2.45M -316,719 -82%
AO
44
Allen Operations
New York
$697K – – –
EH
45
Equitable Holdings
New York
$684K +$27.1K +3,500 +6%
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$672K +$463K +59,771 New
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$666K +$459K +59,230 New
American Century Companies
48
American Century Companies
Missouri
$651K +$190K +24,586 +74%
Swiss National Bank
49
Swiss National Bank
Switzerland
$640K -$34.9K -4,500 -7%
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$626K +$430K +55,468 +23,404%
1
2
3 4 5

DNA Hedge Fund Activity: Q2 2025 in Review

165 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Ginkgo Bioworks (DNA) for Q2 2025, worth a combined $375M — up 105% from $183M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new DNA positions and 35 closed out — a net gain of 1 holder — while 46 added to existing stakes and 34 trimmed.

The largest buyer was BlackRock, adding an estimated $14M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $8.34M sold.

  • 165 institutional investors held Ginkgo Bioworks (DNA) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $375M of Ginkgo Bioworks stock for Q2 2025, up 105% quarter-over-quarter.
  • 36 funds opened new Ginkgo Bioworks positions in Q2 2025 and 35 closed out, a net change of +1 holder.
  • The largest Ginkgo Bioworks buyer in Q2 2025 was BlackRock, an estimated $14M added.
  • The largest Ginkgo Bioworks seller in Q2 2025 was EcoR1 Capital, an estimated $8.34M sold.

Based on aggregated 13F filings for Q2 2025.